blackout.network
Original diagram of places named in the Science reconstruction of early Bundibugyo Ebola spread in eastern Congo. Locations are approximate.

THE WIRE / DISEASE

A new reconstruction finds human travel, not population size, drove Ebola's early spread in Congo.

Mobile-phone data almost perfectly predicted where Bundibugyo Ebola would appear next, researchers reported, in what is now Congo's largest outbreak on record.

Seen Nov 17, 5:17 AM ET · Updated Nov 18, 1:26 PM ET · Desk brief Nov 17, 4:40 PM ET

What happened

On November 17, CIDRAP reported a study, published last week in the journal Science, in which a team led by researchers in the Democratic Republic of the Congo paired case and testing records with mobile-phone data. They concluded that human movement — not geography or destination population size — propelled the early spread of Bundibugyo Ebola virus in an outbreak that CIDRAP says is now Congo's largest on record and the fastest-growing Ebola outbreak in history.

As of that CIDRAP report, the U.S. Centers for Disease Control and Prevention listed 11,463 cases and 5,597 deaths, with Ebola affecting 67 health zones in eight provinces. The study, CIDRAP said, is the most detailed epidemiologic reconstruction so far of the rapid expansion within Ituri province and in bordering provinces.

The person with the earliest known infection developed symptoms on April 25. An earlier sample from a suspected case, from April 9, had invalid results — which the authors said could reflect insufficient blood, poor samples from deceased patients, or trouble moving samples to laboratories that were only then being set up. The epidemic was declared in mid-May. From May 10 to June 1, the number of health zones reporting infections rose by 12 and the number of affected areas by 49. The estimated early case-doubling time was 10 days. Among 555 known test outcomes with age, sex and symptom onset recorded, the median age was 34.5 years and women accounted for 59 percent of confirmed cases.

Background and history

This is an outbreak of Bundibugyo Ebola virus. CIDRAP, citing the paper, says no approved vaccines or treatments target Bundibugyo, although a vaccine and therapeutic trial are under way. That is a different position from outbreaks of Zaire ebolavirus, for which licensed vaccines and treatments already exist.

Co-first author Pierre Akilimali of the University of Kinshasa, in a University of Oxford news release quoted by CIDRAP, said Congolese teams were collecting and analysing individual-level case data within days of the alert, under difficult conditions. More than 50 researchers worked on questions from the response teams, including where to put resources and what it would cost to care for patients.

The same CIDRAP article noted that Kenya has begun a 42-day countdown after its last surviving Ebola patient was released, and that Nigeria has ended a 21-day monitoring period after its only infected patient was discharged and 62 contacts were cleared. Those are separate, smaller events linked to the wider regional picture, not findings of the Science paper itself.

Our analysis

The practical claim is sharp: destination population size did not predict where the virus went, but mobility did. CIDRAP reports that the risk of Bundibugyo appearing fell with distance from Bunia and Mongbwalu in Ituri, and from Rwampara in Uganda, out to about 100 kilometres, then rose slightly between 150 and 200 kilometres — a pattern the authors link to travel corridors and then local growth. Co-senior authors Moritz Kraemer of Oxford and Samuel Scarpino of Northeastern University said human mobility data "predicted almost perfectly where this virus would appear next," and argued for putting laboratory and care capacity permanently in those high-risk settings.

The reconstruction also says the virus was circulating weeks before the mid-May declaration, which would have shortened the window for stopping it at the source. Combined with the lack of approved medical countermeasures for Bundibugyo, that helps explain how this became, in the authors' and CIDRAP's wording, the fastest-growing Ebola outbreak on record.

This paper explains spread inside Congo and nearby corridors. It is not evidence of a threat to the United States. Our read of the risk to a general U.S. reader is medium only because the underlying outbreak is large and ongoing.

What to watch next

If the mobility pattern holds, new zones should continue to appear along known travel corridors, and the value of the work will be whether lab and treatment capacity is actually placed there. Watch also for results from the Bundibugyo vaccine and therapeutic trials, and for official case totals from CDC, WHO and Africa CDC.

No action is needed in the United States.

Confidence and rank

7MAJOR

Our confidence is high. The account is from a CIDRAP report of a Science paper and a University of Oxford news release, with CDC totals current as of November 17. We have not independently re-analyzed the underlying mobility data.

Our read of the risk to a general reader is medium — The outbreak in Congo is large and still growing; this paper explains how it spread there. It is not evidence of spread to the United States.

How we rank

Ranks run from 0 to 10 and follow published scoring rules, including how widely a story reaches and how many independent sources report it. A high rank is not the same as a high risk to you. How we score →

Post on X

Image credits